InnoCan Pharma Corporation (CSE:INNO)

Canada · Delayed Price · Currency is CAD

6.58

-0.08 (-1.20%)

Apr 10, 2026, 11:26 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Other Operations		109.00K	135.00K	-	-
Other Operations Growth		-19.26%	-	-	-
Online Sales		13.55M	2.42M	-	-
Online Sales Growth		458.91%	-	-	-
Pharmaceuticals		-	-	196.00K	8.00K
Pharmaceuticals Growth		-	-	2350.00%	-
Total		13.66M	2.56M	196.00K	8.00K
Total Growth		433.69%	1205.61%	2350.00%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States		13.55M	2.42M	34.00K	-
United States Growth		460.53%	7008.82%	-	-
Rest of The World		109.00K	59.00K	41.00K	8.00K
Rest of The World Growth		84.75%	43.90%	412.50%	-
United Kingdom		-	83.00K	-	-
France		-	-	61.00K	-
Poland		-	-	60.00K	-
Total		13.66M	2.56M	196.00K	8.00K
Total Growth		433.69%	1205.61%	2350.00%	-

Source: S&P Global Market Intelligence.